Compare PAXS & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAXS | SIBN |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 680.0M | 622.3M |
| IPO Year | 2021 | 2018 |
| Metric | PAXS | SIBN |
|---|---|---|
| Price | $14.65 | $11.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $23.88 |
| AVG Volume (30 Days) | 146.3K | ★ 617.1K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,301,000.00 |
| Revenue This Year | N/A | $16.95 |
| Revenue Next Year | N/A | $14.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $13.74 | $12.15 |
| 52 Week High | $16.56 | $21.89 |
| Indicator | PAXS | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 52.75 | 34.72 |
| Support Level | $14.30 | N/A |
| Resistance Level | $14.84 | $13.87 |
| Average True Range (ATR) | 0.19 | 0.76 |
| MACD | 0.04 | -0.15 |
| Stochastic Oscillator | 65.58 | 3.28 |
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.